SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DaiS who wrote (20113)3/25/1999 3:29:00 PM
From: VLAD   of 23519
 
DaiS,

I don't expect you to get any decent information right now. but I figure if you start to probe to find a good person to speak with at Zeneca IR in London that once the merger is complete and the new European countries are launched, you will be the best source of information regarding MUSE sales in all of Astra's original territories. Also, we no longer have any language barrier to cross. You are British and Astra/Zeneca will then have it's corporate Head Quarters in London. Astra/Zeneca's IR Department in London will be the best source of information for how MUSE sales are doing in Europe and the other original Astra territories. Maybe we can get one or two other British Vivus investors involved to tap information out from Astra/Zeneca regarding MUSE sales. Thanks and good luck!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News